Chemotherapy dosing in obese patients: the real evidence

Obesity is linked to many disease states including cancer and has been shown to increase mortality. Body surface area is the method used for dosing chemotherapy. This can potentially lead to either increased toxicity or decreased efficacy. Oncologists tend to dose-reduce obese patients despite data suggesting otherwise.